BioCryst Pharmaceuticals, Inc.BCRXNASDAQ
Loading
Current Ratio Over TimeFair Value
Percentile Rank43
3Y CAGR-25.0%
5Y CAGR-7.6%
Year-over-Year Change
Current ratio (current assets / current liabilities)
3Y CAGR
-25.0%/yr
vs +31.3%/yr prior
5Y CAGR
-7.6%/yr
Recent deceleration
Acceleration
-56.4pp
Decelerating
Percentile
P43
Within normal range
vs 5Y Ago
0.7x
Contraction
Streak
4 yr
Consecutive declineFair Value
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 2.06 | -21.6% |
| 2024 | 2.63 | -20.4% |
| 2023 | 3.31 | -32.4% |
| 2022 | 4.90 | -10.3% |
| 2021 | 5.46 | +78.1% |
| 2020 | 3.06 | +72.2% |
| 2019 | 1.78 | +8.1% |
| 2018 | 1.65 | -1.8% |
| 2017 | 1.68 | +36.0% |
| 2016 | 1.23 | - |